Cellares is an Integrated Development and Manufacturing Organization (IDMO) focused on the automated, large-scale manufacture of cell therapies for biopharmaceutical partners.
The company develops fully automated, cGMP-compliant manufacturing and quality-control platforms—Cell Shuttle™ for end-to-end production and Cell Q™ for in-process and release testing—and builds Smart Factory networks to increase throughput, consistency, and reduce per-patient costs.
Leadership & Board
Currently, no data available
Latest Estimated Valuation
Estimated Valuation―
Estimated Valuation―
Total Amount Raised$257M
Total Amount Raised$257M
Total Funding Rounds1
Total Funding Rounds1
Latest Funding Amount$257M
Latest Funding Amount$257M
Latest Funding RoundSeries D
Latest Funding RoundSeries D
Post-Money Valuation―
Post-Money Valuation―
Funding Round
Jan 28, 2026
Series D
$257.00M
―
Investors
Series D
Series D
Series D
Series D
Series D
Series D
Series D
